CA2211794A1 - Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide - Google Patents

Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide

Info

Publication number
CA2211794A1
CA2211794A1 CA002211794A CA2211794A CA2211794A1 CA 2211794 A1 CA2211794 A1 CA 2211794A1 CA 002211794 A CA002211794 A CA 002211794A CA 2211794 A CA2211794 A CA 2211794A CA 2211794 A1 CA2211794 A1 CA 2211794A1
Authority
CA
Canada
Prior art keywords
active principle
electrodes
electrode
anionic oligosaccharide
iontophoresis device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002211794A
Other languages
French (fr)
Other versions
CA2211794C (en
Inventor
Daniel Muller
Alain Barbier
Henry Saunal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe National Elf Aquitaine
Sanofi Aventis France
Akzo Nobel NV
Original Assignee
Sanofi
Daniel Muller
Alain Barbier
Henry Saunal
Elf Aquitaine
Akzo Nobel Nv
Sanofi-Synthelabo
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9500757A external-priority patent/FR2729574B1/en
Application filed by Sanofi, Daniel Muller, Alain Barbier, Henry Saunal, Elf Aquitaine, Akzo Nobel Nv, Sanofi-Synthelabo, Sanofi-Aventis filed Critical Sanofi
Publication of CA2211794A1 publication Critical patent/CA2211794A1/en
Application granted granted Critical
Publication of CA2211794C publication Critical patent/CA2211794C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

Le dispositif comporte une électrode négative réversible, en contact avec un élément réservoir contenant un électrolyte renfermant le principe actif oligosaccharide anionique, notamment pentasaccharide, sous une forme au moins partiellement ionisée, une électrode positive, seule ou associée à un réceptacle contenant un électrolyte, et un générateur de signaux électriques connectable aux deux électrodes. Le générateur est agencé pour appliquer, entre les électrodes, des signaux électriques de tension moyenne telle que la densité du courant moyen généré entre les électrodes est comprise entre 0,05 et 0.25 mA/cm2. La quantité de principe actif présente dans l'élément réservoir associé à l'électrode négative représente 0,5 mg à 12 mg par cm2 d'électrode et par mAh de courant passant par cm2 d'électrode.The device comprises a reversible negative electrode, in contact with a reservoir element containing an electrolyte containing the active principle anionic oligosaccharide, in particular pentasaccharide, in an at least partially ionized form, a positive electrode, alone or associated with a receptacle containing an electrolyte, and an electrical signal generator connectable to the two electrodes. The generator is arranged to apply, between the electrodes, electrical signals of medium voltage such that the density of the average current generated between the electrodes is between 0.05 and 0.25 mA / cm2. The quantity of active principle present in the reservoir element associated with the negative electrode represents 0.5 mg to 12 mg per cm2 of electrode and per mAh of current passing through cm2 of electrode.

CA002211794A 1995-01-24 1996-01-24 Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide Expired - Lifetime CA2211794C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9500757A FR2729574B1 (en) 1995-01-24 1995-01-24 IONOPHORESIS DEVICE FOR THE TRANSCUTANEOUS ADMINISTRATION OF AN ANIONIC OLIGOSACCHARIDE ACTIVE PRINCIPLE
FR95/00757 1995-01-24
PCT/FR1996/000114 WO1996022808A1 (en) 1995-01-24 1996-01-24 Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide

Publications (2)

Publication Number Publication Date
CA2211794A1 true CA2211794A1 (en) 1996-08-01
CA2211794C CA2211794C (en) 2006-06-27

Family

ID=36644838

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002211794A Expired - Lifetime CA2211794C (en) 1995-01-24 1996-01-24 Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide

Country Status (1)

Country Link
CA (1) CA2211794C (en)

Also Published As

Publication number Publication date
CA2211794C (en) 2006-06-27

Similar Documents

Publication Publication Date Title
ATE192664T1 (en) IONTOPHORESIS DEVICE FOR TRANSDERMAL ADMINISTRATION OF ANIONIC OLIGOSACCARIDE TYPE ACTIVE SUBSTANCES
FR2506165A1 (en) DEVICE FOR IONOPHORESIS TREATMENT
Lembeck et al. Substance P in peripheral sensory processes
EP0904801A3 (en) Method of detecting events or conditions in an iontophoretic drug delivery system
CA2136337A1 (en) Electrical Stimulation for Treatment of Incontinence and Other Neuro-Muscular Disorders
EP0337642A3 (en) Transdermal drug delivery device
FR2616333A1 (en) IONOPHORESIS METHOD FOR ADMINISTERING A DISSOLVED OR PARTIALLY DISSOLVED SUBSTANCE, BY PERCUTANEOUS OR PERUNGUAL ROUTE AND CORRESPONDING DEVICE
KR920016113A (en) Method and apparatus for regenerating electrode during iontophoresis
AU591997B2 (en) Transdermal drug delivery device
ZA927122B (en) Break-apart needle electrode system.
EP1195175A3 (en) Iontoporesis device
CA2079462A1 (en) Iontophoretic delivery device
WO2000057947A3 (en) Bipolar sensor for muscle tissue action potential duration estimation
Strumwasser et al. Prolonged and patterned direct extracellular stimulation of single neurons
DE69512083T2 (en) DEVICE FOR INCREASING THE ACTIVE SUBSTANCE ADMINISTRATION BY ELECTRO TRANSPORT
CA2288006A1 (en) Humane crustacean processor
CA2211794A1 (en) Iontophoresis device for the transcutaneous delivery of an active principle such as an anionic oligosaccharide
CA2132348A1 (en) User Activated Iontophoretic Device and Method for Using Same
CA2001446A1 (en) Iontophoresis electrode
NZ331051A (en) Instant release forms of gelled active substances
BR0011459A (en) Ionophoretic drug delivery device
Lovick Enkephalin blocks primary afferent depolarization of Aδ tooth pulp afferents evoked by stimulation in nucleus raphe magnus in the decerebrate cat
FR2627918A1 (en) Generating bidirectional asymmetric pulses for electrotherapy - using generator connected to frequency modulator with counter and relay controlling number of pulses and current polarity
RU94023351A (en) Устройство управления и индикации для системы катодной защиты кузова автомобиля от коррозии
FR2724115B1 (en) IONOPHORESIS DEVICE FOR THE TRANSCUTANEOUS DELIVERY OF AN ACTIVE INGREDIENT TO A SUBJECT PROVIDING PRECISE DOSAGE CONTROL

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160125